Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

756 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Infection with SARS-CoV-2 Variants Is Associated with Different Long COVID Phenotypes.
Spinicci M, Graziani L, Tilli M, Nkurunziza J, Vellere I, Borchi B, Mencarini J, Campolmi I, Gori L, Giovannoni L, Amato C, Livi L, Rasero L, Fattirolli F, Marcucci R, Giusti B, Olivotto I, Tomassetti S, Lavorini F, Maggi L, Annunziato F, Marchionni N, Zammarchi L, Bartoloni A. Spinicci M, et al. Among authors: olivotto i. Viruses. 2022 Oct 27;14(11):2367. doi: 10.3390/v14112367. Viruses. 2022. PMID: 36366465 Free PMC article.
Prognostic value of cardiopulmonary exercise testing in patients with transthyretin cardiac amyloidosis.
Silverii MV, Argirò A, Baldasseroni S, Fumagalli C, Zampieri M, Guerrieri L, Bartolini S, Mazzoni C, Burgisser C, Tomberli A, Di Mario C, Marchionni N, Olivotto I, Perfetto F, Fattirolli F, Cappelli F. Silverii MV, et al. Among authors: olivotto i. Intern Emerg Med. 2023 Mar;18(2):585-593. doi: 10.1007/s11739-022-03125-3. Epub 2022 Nov 18. Intern Emerg Med. 2023. PMID: 36396841
Determinants of health status in older patients with transthyretin cardiac amyloidosis: a prospective cohort study.
Fumagalli C, Ponti L, Smorti M, Pozza F, Argirò A, Zampieri M, Di Mario C, Marfella R, Sardu C, Paolisso G, Olivotto I, Perfetto F, Ungar A, Marchionni N, Cappelli F. Fumagalli C, et al. Among authors: olivotto i. Aging Clin Exp Res. 2024 Apr 10;36(1):89. doi: 10.1007/s40520-024-02750-6. Aging Clin Exp Res. 2024. PMID: 38598143 Free PMC article.
Myocarditis and COVID-19 related issues.
Ciabatti M, Zocchi C, Olivotto I, Bolognese L, Pieroni M. Ciabatti M, et al. Among authors: olivotto i. Glob Cardiol Sci Pract. 2023 Sep 30;2023(4):e202328. doi: 10.21542/gcsp.2023.28. eCollection 2023 Sep 30. Glob Cardiol Sci Pract. 2023. PMID: 38404624 Free PMC article. Review.
Long-term multisystemic efficacy of migalastat on Fabry-associated clinical events, including renal, cardiac and cerebrovascular outcomes.
Hughes DA, Bichet DG, Giugliani R, Hopkin RJ, Krusinska E, Nicholls K, Olivotto I, Feldt-Rasmussen U, Sakai N, Skuban N, Sunder-Plassmann G, Torra R, Wilcox WR. Hughes DA, et al. Among authors: olivotto i. J Med Genet. 2023 Jul;60(7):722-731. doi: 10.1136/jmg-2022-108669. Epub 2022 Dec 21. J Med Genet. 2023. PMID: 36543533 Free PMC article.
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial.
Olivotto I, Oreziak A, Barriales-Villa R, Abraham TP, Masri A, Garcia-Pavia P, Saberi S, Lakdawala NK, Wheeler MT, Owens A, Kubanek M, Wojakowski W, Jensen MK, Gimeno-Blanes J, Afshar K, Myers J, Hegde SM, Solomon SD, Sehnert AJ, Zhang D, Li W, Bhattacharya M, Edelberg JM, Waldman CB, Lester SJ, Wang A, Ho CY, Jacoby D; EXPLORER-HCM study investigators. Olivotto I, et al. Lancet. 2020 Sep 12;396(10253):759-769. doi: 10.1016/S0140-6736(20)31792-X. Epub 2020 Aug 29. Lancet. 2020. PMID: 32871100 Clinical Trial.
The Inglorious Art.
Olivotto I. Olivotto I. JAMA Cardiol. 2022 Feb 1;7(2):127. doi: 10.1001/jamacardio.2021.5701. JAMA Cardiol. 2022. PMID: 35080580 No abstract available.
756 results